James – Cohort studies
James is a part of a cohort study. He has been treated excellently by the medical professionals running the study but has experienced side effects from the medications they gave him.
James was a part of a cohort study investigating vascular diseases (e.g. strokes, heart attacks). He was invited to join the study through his GP as he had experienced a transient ischemic attack (TIA). He was motivated to join the study because he could be seen by a specialist quicker than he would otherwise. As part of his involvement in the cohort study, James filled out questionnaires about his lifestyle and had a series of tests including an MRI and ultrasound. He says that he could not have asked for better treatment by the professionals running the study. He particularly appreciated how they took the time to summarise James’ illness, what had happened, and what medication he needed to take.
After his TIA, James was prescribed statins to reduce his cholesterol, aspirin and ramipril to reduce his blood pressure, and dipyridamole to keep his blood flowing. He found this quite overwhelming as he had never taken this much medication before. After being on the medications for a few weeks, James experienced another TIA and had to go back to the hospital. This was upsetting for him as he is a full-time carer for his wife and needs to be healthy to look after her. James decided to stop taking the statins after watching a television programme where another person was having similar symptoms on statins. After James stopped taking the statins, he went back to the hospital for a follow-up appointment and he filled out another questionnaire as part of the cohort study. The researchers also provided him with a blood pressure machine so that he could take his blood pressure 3 times a day at home. At this appointment, James told the doctors running the clinic and the study team that he had stopped taking the statins, and they agreed that he should stop taking them.
About 3 years ago, James started experiencing nose bleeds, a cough, and sore muscles. One day, when James was working on his allotment, he could not get up. He believes these symptoms were side-effects from the ramipril, so he stopped taking this medicine. After one day of stopping taking this tablet, James described himself as feeling much better. When James spoke to his doctor about this, he was tested for polymyalgia rheumatica (a condition that causes pain and muscle stiffness), but the test came back negative, so he was put on steroids to restore his muscle mass. James reported his problems to the health professionals he saw at the clinic and at each study appointment. James did not think about leaving the study because he believed that participating in the cohort study research was necessary to access both the medication and the rapid-access clinic, and he feared having another TIA or a stroke.
Towards the end of his time on the study, James began to feel “fed up” because every questionnaire included the same questions. Some test results suggested he was experiencing cognitive decline, but James thinks this was because he misheard one of the instructions. James also flagged to the researchers that their definition in the questionnaires of physical activity excluded housework; the researchers seemed to take note as it was later included in the questionnaire. James; participation in the study finished after 10 years.
James is also in another cohort a study looking at pain in relation to lifestyle factors. The study researchers send James information about the project and a questionnaire. His motivation for joining the study is to help other people.
Interview conducted in 2019.